| Financial Year |
March 31 2023 |
| Monetary Funds |
93,094,213.24 |
| Held-for-trading Financial Assets |
70,290,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
20,477,626.41 |
| Advances to Suppliers |
4,310,233.55 |
| Other Receivables |
2,715,207.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
151,923,111.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
286,611,729.62 |
| Total Current Assets |
629,422,121.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,974,075.88 |
| Fixed Assetes |
309,246,162.95 |
| Under-construction Projects |
193,251,485.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
104,630,295.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
24,778,050.69 |
| Other Non-Current Assets |
23,796,643.61 |
| Sub-Total of Non-Current Assets |
742,266,713.77 |
| Total Assets |
1,371,688,835.27 |
| Short-Term Loans |
50,041,708.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,477,242.42 |
| Accounts Payable |
38,212,436.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,780,095.16 |
| Taxes Payable |
2,655,450.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
127,285,172.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,398,339.68 |
| Sub-Total of Current Liabilities |
285,068,442.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
395,759.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,894,417.94 |
| Total Liabilities |
305,962,860.59 |
| Paid-In Capital(Or Share Stock) |
355,491,770.00 |
| Capital Surplus |
115,548,351.90 |
| Surplus Reserve |
78,021,254.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
438,427,801.38 |
| Minority Stockholder's Interest |
76,035,296.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
989,690,678.19 |
| Owner's Equity（Stockholder's Equity） |
1,065,725,974.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,371,688,835.27 |
